Takeabreak2020-08-25 21:55
$万基遗传(MYGN)$ 今年至今跌去30%+的还有$Adma生物制品(ADMA)$, $BioDelivery科学国际(BDSI)$, CRVS查看全文
chuminhua2020-05-23 23:21
5/20,FDA批准了Foundation Medicine和Myriad Genetics$万基遗传(MYGN)$ 的伴随诊断测试,用于AZ和MSD的PARP抑制剂Lynparza(olaparib),用于筛选出适合治疗的转移性去势抵抗性前列腺癌患者。查看全文
网络异常请稍后再试2020-05-12 07:12
$万基遗传(MYGN)$
2019/8/13盘后财报,MISS,8/14号暴跌43%
2019/11/4盘后财报,MISS,11/5号暴跌40%;
2020/2/6盘后财报,MISS,2/7号暴跌30%;
2020/5/5盘后财报,MISS,5/6号跌4%;
这股真是有个性啊。。。。。。查看全文
$万基遗传(MYGN)$ SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals Filed: 2016-01-26 AccNo: 0001033427-16-000083 Size: 96 KB 网页链接
$万基遗传(MYGN)$ 美东时间 2016-02-02 16:30 Q2 2016 Myriad Genetics Inc Earnings Call 网页链接
$万基遗传(MYGN)$ 美东时间 2016-01-11 12:30 Myriad Genetics Inc at JPMorgan Healthcare Conference 网页链接
$万基遗传(MYGN)$ 内部交易: 2015-12-08,Director,Phanstiel S. Louise ,卖出,5000普通股, $44.00
$万基遗传(MYGN)$ 8-K - Current report Filed: 2015-12-07 AccNo: 0001193125-15-396579 Size: 128 KBItem 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain OfficersItem 5.07: Submission of...
$万基遗传(MYGN)$ 8-K - Current report Filed: 2015-11-03 AccNo: 0001193125-15-364304 Size: 6 MBItem 2.02: Results of Operations and Financial ConditionItem 7.01: Regulation FD DisclosureItem 9.01: Financial Statements and Exhibits 网页链接
$万基遗传(MYGN)$ 10-Q - Quarterly report [Sections 13 or 15(d)] Filed: 2015-11-04 AccNo: 0001193125-15-365547 Size: 3 MB 网页链接
$万基遗传(MYGN)$ 10-Q - Quarterly report [Sections 13 or 15(d)] Filed: 2015-11-04 AccNo: 0001193125-15-365547 Size: 3 MB 网页链接
$万基遗传(MYGN)$ 8-K - Current report Filed: 2015-11-03 AccNo: 0001193125-15-364304 Size: 6 MBItem 2.02: Results of Operations and Financial ConditionItem 7.01: Regulation FD DisclosureItem 9.01: Financial Statements and Exhibits 网页链接
$万基遗传(MYGN)$ 内部交易: 2015-10-28,Chief Scientific Officer,LANCHBURY JERRY S ,卖出,50962普通股, $41.86